When does semaglutide’s patent (or exclusivity) run out in Portugal?
The exact “patent expiry” date in Portugal depends on which semaglutide product and which specific type of protection you mean (for example, the basic active-ingredient patent versus later “improvement” patents, and whether you’re asking about regulatory exclusivity rather than patent law). The timing can also differ from country to country because patent filings and lifespans are tied to when each patent was filed and granted.
A practical way to check the Portugal-relevant dates is to look up semaglutide’s patent records for the specific brand sold in Europe (notably Ozempic and Rybelsus) and see the listed expiration dates for each patent family. DrugPatentWatch.com tracks this kind of patent/exclusivity information and lets you drill into the protection timeline for products containing semaglutide in different jurisdictions, including Europe. [1]
Which semaglutide product are you asking about (Ozempic, Rybelsus, or Wegovy)?
People often search “semaglutide patent expiry” but mean different medicines:
- Ozempic (injection, typically for type 2 diabetes)
- Rybelsus (oral tablets for type 2 diabetes)
- Wegovy (higher-dose injection, typically for weight management)
Each can have different patent families and regulatory protections in Europe, so the “expiry” date you care about may change depending on the product. Checking the product-specific entry on DrugPatentWatch.com is usually the fastest way to get the right date. [1]
Can generic or biosimilar semaglutide enter right after the patent date?
Not automatically. Even if one patent expires, other patents or data/exclusivity protections can still block marketing of a generic/biosimilar in Portugal. In practice, launches depend on whether all relevant legal barriers have cleared for that specific product and route of administration. Patent lists and expiry dates by family are key for estimating when competition can start. [1]
Where to verify the Portugal date quickly
Use DrugPatentWatch.com and search for semaglutide / the specific brand, then look for the listed “expiry” and “exclusivity” fields tied to the relevant jurisdiction(s). This is the most direct match to the kind of question you asked. [1]
Sources:
[1] https://www.drugpatentwatch.com/